ArticleJournal of cardiovascular pharmacology2015

MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.

Duaa Dakhlallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.